Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 11648561 was granted and assigned to NeuMoDx Molecular on May, 2023 by the United States Patent and Trademark Office. | 11648561 | May 16, 2023 | |||||||
Patent 11338295 was granted and assigned to NeuMoDx Molecular on May, 2022 by the United States Patent and Trademark Office. | 11338295 | May 24, 2022 | |||||||
Patent 9382532 was granted and assigned to NeuMoDx Molecular on July, 2016 by the United States Patent and Trademark Office. | 9382532 | July 5, 2016 | |||||||
Patent 9339812 was granted and assigned to NeuMoDx Molecular on May, 2016 by the United States Patent and Trademark Office. | 9339812 | May 17, 2016 | |||||||
Patent 9050594 was granted and assigned to NeuMoDx Molecular on June, 2015 by the United States Patent and Trademark Office. | 9050594 | June 9, 2015 | |||||||
11273448 | March 15, 2022 | ||||||||
Patent 9738887 was granted and assigned to NeuMoDx Molecular on August, 2017 by the United States Patent and Trademark Office. | 9738887 | August 22, 2017 | |||||||
Patent 11485968 was granted and assigned to NeuMoDx Molecular on November, 2022 by the United States Patent and Trademark Office. | 11485968 | November 1, 2022 | |||||||
Patent 9101930 was granted and assigned to NeuMoDx Molecular on August, 2015 by the United States Patent and Trademark Office. | 9101930 | August 11, 2015 | |||||||
Patent 9540636 was granted and assigned to NeuMoDx Molecular on January, 2017 by the United States Patent and Trademark Office. | 9540636 | January 10, 2017 | |||||||
Patent 9441219 was granted and assigned to NeuMoDx Molecular on September, 2016 by the United States Patent and Trademark Office. | 9441219 | September 13, 2016 | |||||||
Patent 10010888 was granted and assigned to NeuMoDx Molecular on July, 2018 by the United States Patent and Trademark Office. | 10010888 | July 3, 2018 | |||||||
Patent 9452430 was granted and assigned to NeuMoDx Molecular on September, 2016 by the United States Patent and Trademark Office. | 9452430 | September 27, 2016 | |||||||
Patent 9403165 was granted and assigned to NeuMoDx Molecular on August, 2016 by the United States Patent and Trademark Office. | 9403165 | August 2, 2016 | |||||||
Patent 9637775 was granted and assigned to NeuMoDx Molecular on May, 2017 by the United States Patent and Trademark Office. | 9637775 | May 2, 2017 | |||||||
Patent 10239060 was granted and assigned to NeuMoDx Molecular on March, 2019 by the United States Patent and Trademark Office. | 10239060 | March 26, 2019 | |||||||
Patent 9433940 was granted and assigned to NeuMoDx Molecular on September, 2016 by the United States Patent and Trademark Office. | 9433940 | September 6, 2016 | |||||||
Patent 10041062 was granted and assigned to NeuMoDx Molecular on August, 2018 by the United States Patent and Trademark Office. | 10041062 | August 7, 2018 | |||||||
Patent 10557132 was granted and assigned to NeuMoDx Molecular on February, 2020 by the United States Patent and Trademark Office. | 10557132 | February 11, 2020 | |||||||
Patent 11142757 was granted and assigned to NeuMoDx Molecular on October, 2021 by the United States Patent and Trademark Office. | 11142757 | October 12, 2021 | |||||||
Patent 9539576 was granted and assigned to NeuMoDx Molecular on January, 2017 by the United States Patent and Trademark Office. | 9539576 | January 10, 2017 | |||||||
Patent 9604213 was granted and assigned to NeuMoDx Molecular on March, 2017 by the United States Patent and Trademark Office. | 9604213 | March 28, 2017 | |||||||
Patent 9499896 was granted and assigned to NeuMoDx Molecular on November, 2016 by the United States Patent and Trademark Office. | 9499896 | November 22, 2016 | |||||||
10633647 | April 28, 2020 | ||||||||
Patent 10226771 was granted and assigned to NeuMoDx Molecular on March, 2019 by the United States Patent and Trademark Office. | 10226771 | March 12, 2019 |